Under the settlement, the U.K.-based pharmaceutical company agreed to pay $24 million cash and donate up to $6 million of generic products, including drugs for addiction treatment.
In exchange, Mallinckrodt will be dismissed from the lawsuit filed by Cuyahoga and Summit counties in Ohio, which were chosen to serve as bellwethers in multidistrict litigation over the opioid epidemic.
The company will now focus on reaching a “global resolution” for its remaining opioid lawsuits, Mark Cassey, Mallinckrodt’s general counsel, told TheStreet.
More articles on pharmacy:
Civica Rx says it isn’t afraid of competition
Cigna rolls out plan to fully cover expensive gene therapies
Rutgers to close 3 on-campus pharmacies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
